OneCell Diagnostics

Fighting Cancer one cell at a time

Fighting Cancer one cell at a time

Choose the treatment which is right for you

Choose the treatment which is right for you

Let your DNA guide your recovery

Let your DNA guide your recovery

About Us

OneCell DiagnosticsTM is an upcoming precision oncology company providing comprehensive genomic solutions for better cancer management. Our cutting-edge Next-Generation Sequencing technology in combination with strong bioinformatics platforms can help Oncologists devise precise and effective treatment/ testing options for patients at various stages of cancer, difficult or rare cancers or at risk for cancer.

Our tests are affordable, and offer deeper coverage of key actionable biomarkers that impact on initiation, development, progression and therapeutic evasion of the disease with high precision and reliability. These tests are well suited to detect ctDNA in liquid and tissue biopsies with high sensitivity and specificity.

Information for Patients

Cancer can be demanding and high cost of NGS-based comprehensive genomic profiling across the world which limits their use and precludes underprivileged patients from leveraging the strengths of these life-saving tests. We recognize this problem and are committed to transforming patient care by providing these tests at affordable rates and of international standards.

Information for Clinicians

We offer a diverse portfolio of affordable NGS based comprehensive genomic assays for multiple cancer types that can help identify key actionable biomarkers to help recommend rationale and validated precision treatment options for your patients including Chemotherapy, Targeted Therapy, and Immunotherapy.

Tests and Services

Comprehensive genomic panel to detect rare mutations for actionable insights.

Rapid AI/ML based testing of genomic signatures such as HRD, MSI, TMB and PDL1

Testimonials

What Our Customers Are Saying

Lorem ipsum is simply dummy text of printing and typesetting industry lorem ipsum been Lorem ipsum is simply dummy text of printing and typesetting industry lorem ipsum been Lorem ipsum is simply dummy Lorem ipsum is simply dummy text of printing and typesetting industry

- Ann Robinson

Lorem ipsum is simply dummy text of printing and typesetting industry lorem ipsum been Lorem ipsum is simply dummy text of printing and typesetting industry lorem ipsum been Lorem ipsum is simply dummy Lorem ipsum is simply dummy text of printing and typesetting industry

- Ann Robinson

Lorem ipsum is simply dummy text of printing and typesetting industry lorem ipsum been Lorem ipsum is simply dummy text of printing and typesetting industry lorem ipsum been Lorem ipsum is simply dummy Lorem ipsum is simply dummy text of printing and typesetting industry

- Ann Robinson

Lorem ipsum is simply dummy text of printing and typesetting industry lorem ipsum been Lorem ipsum is simply dummy text of printing and typesetting industry lorem ipsum been Lorem ipsum is simply dummy Lorem ipsum is simply dummy text of printing and typesetting industry

- Ann Robinson

    Are you an Oncologist ?

    Connect with us to work together for tests and clinical decision-making

    Press Releases & Events

    OneCellDx and Genetics Institute of America Partner to Launch OncoPredikt HRD Assay

    • Ideal for HRD Screening Pharma Development
    • AI Enabled Algorithm
    • Poster Session at ASCO 2022

    OneCellDx to Present Data on AI and ML-based HRD and CTC testing at 2022 American Society of Clinical Oncology, Annual Meeting

    Associated Meetings

    24th – 26th June 2022

    OneCellDx and Genetics Institute of America Partner to Launch OncoPredikt HRD Assay

    • Ideal for HRD Screening Pharma Development
    • AI Enabled Algorithm
    • Poster Session at ASCO 2022

    OneCellDx to Present Data on AI and ML-based HRD and CTC testing at 2022 American Society of Clinical Oncology, Annual Meeting

    Press Releases & Events

    Collaborative case study for academic center

    Collaborative case study for academic center

    Collaborative case study for academic center DANS (2021) has been hosted virtually in conjunction with…

    Host‑dependent molecular factors

    Host‑dependent molecular factors

    Host‑dependent molecular factors mediating SARS‑CoV‑2 infection Lorem Ipsum is simply dummy text of the printing…